Novartis hears pitches to consolidate its agency roster

Share this article:
Novartis has heard pitches for its consumer and professional advertising business with a view toward consolidating its agency roster into 2-4 integrated shops.
The company's global advertising head, Kurt Graves, told Advertising Age that Novartis was torn between seeking global bulk and creative brawn in both consumer and professional. "Nobody has both," Graves told Advertising Age, adding that he had ruled out consolidating Novartis' advertising business into one holding company, as Sanofi-Synthelabo did recently with Publicis Groupe.
Included in the pitch were Deutsch, which handles Lamisil and Zelnorm DTC, Merkley & Partners, which handles Elidel DTC, and Commonhealth Group's Noesis, which handles Elidel and Lotrel professional, as well as non-roster shops such as InChord's GSW Worldwide, DDB Worldwide, Saatchi & Saatchi. 
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.